Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks.
McDonald EG, Lundby C, Thompson W, Boyd C, Farrell B, Gagnon C, Herbin J, Khuong N, Moriarty F, Pierson T, Scott S, Scott IA, Silvius J, Spinewine A, Steinman MA, Tannenbaum C, Trimble J, Turner JP, Reeve E.
McDonald EG, et al. Among authors: tannenbaum c.
Expert Rev Clin Pharmacol. 2024 May 13. doi: 10.1080/17512433.2024.2355270. Online ahead of print.
Expert Rev Clin Pharmacol. 2024.
PMID: 38739460